Molecular Biology

Molecular Insight Pharmaceuticals is a biopharmaceutical company focused on the research, development and commercialization of innovative molecular imaging pharmaceuticals and targeted radiotherapeutics. The company's product candidates target markets with significant unmet needs in cardiology, oncology, and neurology. Molecular Insight's lead cardiology product candidate, Zemiva(TM) (iodofiltic acid I 123) is in development as a molecular imaging pharmaceutical for the diagnosis of insufficient blood flow to the heart, or cardiac ischemia. The company's second lead product candidate, Azedra, is in development for the diagnosis and treatment of neuroendocrine tumors. Molecular Insight Pharmaceuticals is based in Cambridge, Massachusetts. The company's website is:

Molecular Structure

Molecular Insight Pharmaceuticals is a biopharmaceutical company focused on the research, development and commercialization of innovative molecular imaging pharmaceuticals and targeted radiotherapeutics. The company's product candidates target markets with significant unmet needs in cardiology, oncology, and neurology. Molecular Insight's lead cardiology product candidate, Zemiva(TM) (iodofiltic acid I 123) is in development as a molecular imaging pharmaceutical for the diagnosis of insufficient blood flow to the heart, or cardiac ischemia. The company's second lead product candidate, Azedra, is in development for the diagnosis and treatment of neuroendocrine tumors. Molecular Insight Pharmaceuticals is based in Cambridge, Massachusetts. The company's website is:

Kinetic Molecular Theory

Molecular Insight Pharmaceuticals is a biopharmaceutical company focused on the research, development and commercialization of innovative molecular imaging pharmaceuticals and targeted radiotherapeutics. The company's product candidates target markets with significant unmet needs in cardiology, oncology, and neurology. Molecular Insight's lead cardiology product candidate, Zemiva(TM) (iodofiltic acid I 123) is in development as a molecular imaging pharmaceutical for the diagnosis of insufficient blood flow to the heart, or cardiac ischemia. The company's second lead product candidate, Azedra, is in development for the diagnosis and treatment of neuroendocrine tumors. Molecular Insight Pharmaceuticals is based in Cambridge, Massachusetts. The company's website is:

Aromatherapy Vaporizers

If you have not heard, there is a new aromatherapy device on the market today. They are called vaporizers, and for those who don't know, they are the best things since sliced bread. It is no secret that smoking has many harmful side-effects. Vaporizers use heat to bring plant material to a level where they release the chemicals that you are looking to ingest (not always healthy anyway...ie: tar and nicotene) without creating smoke from the combustion of the herbs. It is a simple principle and one that makes you wonder why nobody has thought of this before. So, if you are a smoker, you may want to see what a vaporizer can do for you.

Brad Paisley Music

I was listening to some music I have on my hard drive this weekend, most of which has not made it into the listening rotation yet. I had picked up a couple of Brad Paisely albums a few years ago, but have not made it around to listening to them. I guess that is one of the downsides to ripping your CDs to your hard drive and deep six'ing the cases. Well, I just listened to She's Everything and what a great song. I am not really a country music junky or someone who listens to it because I want to be a cowboy. I am a fan of good music. Someone once said, "There are two kinds of music, good music and bad music." I couldn't agree with that more.

Copyright 2006 ©www.carribeth.com. All rights reserved.